Glutathione S-transferase activity during pregnancy in the mouse: effects of transstilbene oxide pretreatment
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Thioether formation catalyzed by glutathione S-transferases (GSHTr, EC 2.5.1.18) represents one of the major mechanisms of in uiuo detoxication of xenobiotics (l-31. Recent studies have shown that metabolism of vicinal dihalogens by GSHTr may lead to formation of potent mutagens [4-61. In mammals, essentially all organs are known to possess this enzyme system [l, 71. In contrast to the liver, which contains several forms of GSHTr [l] , human placenta is reported to possess a single form of this enzyme [8, 9] , and its activity is not altered following exposure of pregnant women to tie constituents of cig&ettk smoke'[lO: 111. GSHTr activity has also been detected in the placentas of rabbits, guinea pigs [12, 131, rats [14] , and monkeys [15] . Data are also available on the changes in the titers of placental GSHTr with gestational age in rabbits and guinea pigs [12, rats and mice exposed to 5,6_benzoflavone. In these reports, possible alteration in the placental GSHTr was not considered.
Thus, the question of inducibility of GSHTr during pregnancy warrants further examination. Although in males of both mice and rats the liver GSHTr are inducible enzymes and a number of chemicals including pesticides and carcinogens have been shown to be inducers, the mouse liver enzymes seem to be more responsive [l, 24,251. Therefore, the objectives of the present study were to examine (i) the quantitative changes in the mouse hepatic and placental GSHTr activity due to pregnancy, and (ii) the effects of exposure to a potent inducer of this enzyme system, namely trans-stilbene oxide (TSO) [26-281.
Materials and methods
Young virgin mice of the CD1 strain were purchased from the Charles River Breeding Laboratories and housed for at least 1 week prior to use. Purina 5001 mouse chow and water were given ad lib. Animal rooms were on a 12-hr light/dark schedule.
The date on which a mating plug was observed was designated as day zero of pregnancy. TSO (Aldrich Chemical Co.) in corn oil was administered intraperitoneally once daily for 3 days on either days 9, 10, and 11 or on days 15, 16 and 17 of gestation at doses of 0 (control), 100,300, or 500 mg/kg. Animals were killed 24 hr after the last dose (on day 12 or 18 of gestation) by cervical dislocation.
Placentas and livers were examined in situ for signs of toxicity, removed quickly, weighed, and placed in cold 50 mM Tris buffer, pH 7.4, containing 0.25 M sucrose and 1.0 mM EDTA. Placentas were pooled by litter while maternal livers were processed individually to isolate cytosol by differential centrifugation [25] . Cytosolic GSHTr activity was assayed spectrophotometrically at 37" using 105,OOOg supernatant fluid as the enzyme source and 1 mM l-chloro-2.4-dinitrobenzene (CDNB) and 1 mM reduced glutathione (GSH) as cosubstrates, according to Habig et al. 1291 .
Results and discusszon
The effects of pregnancy on maternal liver GSHTr activity are shown in Fig. 1 . Although the values observed in pregnant animals were slightly lower as compared to non-pregnant controls, there was no statistically significant change in GSHTr titers in relation to gestational stage. Polidoro et al. [14] also reported similar observations for liver GSHTr activity towards CDNB and 1,2-dichloro-4-nitrobenzene (DCNB) at mid-pregnancy compared to nonpregnant rats. However, liver cytosols from i9-to 20-day pregnant rats exhibited a significant increase in CDNB and a decrease in DCNB conjugation activity. Their data also indicated that GSHTr activity againstp-nitrobenzyl~hloride did not change while that towards 1,2-epoxy-3-(p-nitrophenoxy) propane increased due to pregnancy. Earlier, Combes and Stakelum [30] observed depression in sulfobromophthalein conjugation with GSH in the livers of pregnant rats. James el al. [13] reported that hepatic GSHTr activity toward styrene oxide measured in pooled samples of pregnant guinea pigs tended to be slightly lower than in comparable samples from adult males. These reports suggest that the changes in liver GSHTr during pregnancy are unpredictable and vary with each substrate in different animal species. The pretreatment of pregnant mice with TSO resulted in a significant induction of GSHTr in the maternal liver except for the samples examined from Q-day and 18-day pregnant mice receiving 100 mg TSO/kg (Fig. 1) . The magnitude of induction was found to be dose dependent and a maximum of about 3.4-fold increase in activity was observed in l&day pregnant mice receiving 500 mg TSO/ kg. Earlier reports [26-281 have shown a 2-to 4-fold induction of liver GSHTr in male rats pretreated with TSO and the induction was believed to be due to TSO itself and not due to its metabolites [27] . Since isozymes of GSHTr from different sources exhibit overlapping substrate specificity and CDNB serves as a substrate for all the forms [l], it remains unknown whether certain or all of the isozymes of pregnant mouse liver GSHTr are induced by TSO pretreatment.
The pregnant mice treated with TSO appeared healthy and active and continued to gain weight. The great majority of fetuses appeared normal when inspected at sacrifice. Occasionally mice receiving 500 mg TSO/kg exhibited some signs of toxicity as evidenced by pale fetuses and discolored placentas. These placentas were not included in enzyme preparations. Figure 2 shows the changes in the mouse placental GSHTr activity during pregnancy and the effects of TSO pretreatments. At present it is unknown whether the mouse placenta, similar to the human placenta [8, 9] , possesses onlv one form of GSHTr. The data indicate that in untreated mice the GSHTr titers were essentially the same at day 12 and day 18 of gestation. However, using CDNB as a co-substrate, Polidoro ef al. [4] reported about a 50% decrease in rat placental GSHTr activity near term relative to mid-pregnancy. It should be noted, however, that only one sample was examined. On the other hand, no such dramatic changes but a relatively small gradual decline has been observed during pregnancy in rabbit and guinea pig placental GSHTr activity toward CDNB [12, 131. In humans, placental GSHTr activity utilizing styrene oxide as a substrate apparently remains nearlv constant between 8 and 25 weeks-of gestation followed by about a 50% decline at full term 1101. A similar dramatic droo in GSHTr differences exist in the titers of placental GSHTr. activity. The data given in Fig. 2 also indicate that none of the TSO treatments produced changes in placental GSHTr activities that were significantly different from controls. Comparative data on the TSO-caused alterations in placental GSHTr are not currently available for other animal species. In view of the reported ability of TSO to cause induction of GSHTr in the extrahepatic tissues [28] , the observed lack of induction of the mouse placental enzyme was rather unexpected. Although these observations suggest that placental GSHTr. in general, may be refractory to the inductive effects of environmental chemicals, additional data are needed.
In conclusion, the data obtained under the experimental conditions employed indicate the inducibility of liver but not of placental GSHTr in the mouse during pregnancy. Utilizing TSO, the magnitude of induction was dose dependent and is quite comparable to that reported for the male rat. Fig. 2 . Placental glutathione S-transferase activity during pregnancy and the effects of frans-stilbene oxide pretreatment. The experimental details are the same as given in the legend for Fig. 1 . The specific activity is expressed as nmoles of CDNB conju ated/min per g tissue (A) or nmoles CDNB conjugate dp. mm per mg cytosolic protein tB).
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